27
Views
2
CrossRef citations to date
0
Altmetric
Articles

Oral Antibiotic Prophylaxis Can Influence the Inflammatory Response in Aortic Aneurysm Repair: Results of a Randomized Clinical Study

Pages 157-164 | Published online: 18 Jul 2013

References

  • Holzheimer RG. Antibiotic prophylaxis. In: Holzheimer RG, Mannick JA (eds.). Surgical Treatment - Evidence-based and problem-oriented. Zuckschwerdt Verlag, München Bern Wien New York 2001: 722-731.
  • Nichols RL, Holmes JW. Prophylaxis in bowel surgery. Curr Clin Top Infect Dis 1995; 15: 76–96.
  • Hinshaw LB. Pathophysiology of endotoxin action: an overview. In: Novotny A, Spitzer JJ, Ziegler EJ (eds.). Cellular and molecular aspects of endotoxin reactions. Elsevier BV 1990: 419-426.
  • Cannon JG, Tomkins RG, Gelfand JA, et al. Circulating Interleukin-1 and Tumor Necrosis Factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161: 790–84.
  • Van Deventer SJH, Cate JW, Tytgat GNJ. Intestinal endotoxemia. Gastroenterology 1988; 94: 825–831.
  • Knaus WA, Wagner DP. MSOF:epidemiology and prog-nosis. In: Pinsky MR, Matuschak JM (eds). Critical care clinics. Multiple systems organ failure. WB Saunders. Philadelphia 1989: 221-232.
  • Cavaillon JM, Haeffner-Cavaillon N. Cytokines and inflammation. Rev Prat 1993; 43: 547–552.
  • Farkas JC, Calvo-Verjat N, Laurian C, et al. Acute col-orectal ischemia after aortic surgery: pathophysiology and prognostic criteria. Ann Vasc Surg 1991; 6: 1–8.
  • Cabie A, Farkas JC, Fitting C, et al. High levels of por-tal TNF-alpha during abdominal aortic surgery in man. Cytokine 1993 ; 5 (5): 448–453.
  • Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637–647.
  • Ward PA. Ischemia, reperfusion and organ dysfunction: biochemical and cellular events. J Vasc Surg 1993 ; 18: 111.
  • Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF. Multiple organ failure: generalized autodestructive inflam-mation? Arch Surg 1985; 120: 1109-1115.
  • Dinarello CA, Mier JW. Current concepts - lym-phokines. New Engl J Med 1987; 317: 940–945.
  • Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 1992; 216: 117–134.
  • Holzheimer RG, Gross J, Schein M. Pro- and anti-inflammatory cytokine-response in abdominal aortic aneurysm repair: A clinical model of ischemia-reperfusion. Shock 1999; 11: 305–310.
  • Edlund C, Kager L, Malmborg AS, Sjostedt S, Nord CE. Effect of ofloxacin and gastrointestinal microflora in patients undergoing gastric surgery. Eur J Clin Microbiol Infect Dis 1988; 7: 135–143.
  • Leigh DA, Walsh B, Harris K, Hancock P, Travers G. Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers. J Antimicrob Chemother 1988; 22, Suppl C, 115-125.
  • Nord CE. Effect of new quinolones on the human gas-trointestinal microflora. Rev Infect Dis 1988;10 Suppll: S193-S196.
  • Urbaschek R, Becker KP. [Detection of endotoxin in plasma: specificity and value for development and prognosis of infection] Endotoxinnachweis im Plasma: Spezifitat und Aussagekraft fur Entwicklung und Prognose einer Sepsis. Infusionsther Transfusionsmed 1993; 20 Suppl 1: 16–19.
  • Roumen RM, Frieling JT, van Tits HW, van der Vliet JA, Goris RJ. Endotoxemia after major vascular operations. J Vasc Surg 1993; 18: 853–857.
  • Cohen JR, Sardari F, Paul J, et al. Increased intestinal permeability: implications for thoracoabdominal aneurysm repair. Ann Vasc Surg 1992; 6: 433–437.
  • Soong CV, Blair PH, Halliday MI, et al. Bowel ischemia and organ impairment in elective abdominal aortic aneurysm. Br J Surg 1994; 81: 965–968.
  • Soong CV, Halliday MI, Barclay GR, Hood JM, Rowlands BJ, Barros D'SA AA. Intramucosal acidosis and sys-temic host responses in abdominal aortic aneurysm surgery. Crit Care Med 1997; 25: 1472–1479.
  • Leigh DA, Walsh B, Harris K, Hancock P, Travers G. Pharmocokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers. J Antimicrob Chemother 1988; 22, Suppl C: 115-125.
  • Edlund C, Sjostedt S, Nord CE. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis 1997; 29 (4): 383–386.
  • Schwarz M, Isenmann R, Thomsen J, Gaus W, Seger HG. Efficacy of oral ofloxacin for single-dose perioperative prophylaxis in general surgery--a controlled randomized clini-cal study. Langenbecks Arch Surg 2001; 386 (6): 397–401.
  • Periti P, Mazzei T. Antibiotic-induced release of bacteri-al cell wall components in the pathogenesis of sepsis and sep-tic shock: a review. J Chemother 1998; 10 (6): 427–448.
  • Holzheimer RG. Antibiotic induced endotoxin release and clinical sepsis: a review. J Chemother 1999; 13 (Spec Issue 1): 159-172.
  • Gathiram P, Wells MT, Brock-Utne JG, Wessels BC, Gaffin SL. Oral administered nonadsorbable antibiotics pre-vent endotoxemia in primates following intestinal ischemia. J Surg Res 1988; 45 (2): 187–193.
  • van Leeuwen PA, Hong RW, Rounds JD, Rodrick ML, Wilmore D. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotox-in. Surgery 1991; 110 (2): 169–174.
  • lino Y, Toriyama M, Kudo K, Natori Y, You A. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl 1992; 157: 16–20.
  • Soong CV, Blair PH, Halliday MI, et al. Endotoxemia, the generation of the cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair. Eur J Vasc Surg 1993; 7 (5): 534–539.
  • Lau LL, Halliday MI, Lee B, Hannon RJ, Gardiner KR, Soong CV. Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxemia and mucosal barrier dysfunction. Eur J Vasc Endovasc Surg 2000; 19 (6): 619–624.
  • Lamp KC, Rybak MJ, McGrath BJ, Summers KK. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 247–252.
  • Pulverer G, Peters G. Investigations on ofloxacin antibacterial activity and influence on the immune system. Infection 1986;14 Suppl 4: S245–S247.
  • Lamp KC, Rybak MJ, McGrath BJ, Summers KK. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40 (1): 247–252.
  • van den Berg C, de Neeling AJ, Schot CS, Hustinx WN, Wemer J, de Wildt DJ. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24 (5): 619–627.
  • Nitsche D, Schulze C, Oesser S, Dalhoff A, Sack M. Impact of different classes antimicrobial agents on plasma endotoxin activity. Arch Surg 1996; 131 (2): 192–199.
  • Nord CE. Effect of new quinolones on the human gas-trointestinal microflora. Rev Infect Dis 1988; 10 Suppl 1: S193–S196.
  • Holzheimer RG, Hirte JF, Reith B, et al. Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J Endotoxin Res 1996; 3 (3): 261–267.
  • Bouter H, Schippers EF, Luelmo SA, et al. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a ran-domized, placebo-controlled study. Crit Care Med 2002; 30 (1): 38–43.
  • Martinez-Pellus AE, Merino P, Bru M, et al. Endogenous endotoxemia of intestinal origin during cardiopul-monary bypass. Role of type of flow and protective effect of selective digestive decontamination. Intensive Care Med 1997; 23 (12): 1251–1257.
  • Baigrie RJ, Lamont PM, Whiting S, Morris PJ. Portal endotoxin and cytokine responses during abdominal aortic surgery. Br J Surg 1993; 166: 248–251.
  • Fan J, Marshall JC, Jiminez M, Shek PN, Zagorski J, Rotstein OD. Hemorrhagic shock primes for increased expres-sion of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysac-charide. J Immunol 1998; 161: 440–447.
  • Holzheimer RG, Molloy RG, Mendez MV, et al. Multiple organ failure may be influenced by macrophage hypoactivation as well as hyperactivation - importance of the double hit. Eur J Surg 1995; 161: 795–803.
  • Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemi-cal characteristics. J Investig Med 1997; 45: 552–560.
  • Pacher R, Redl H, Frass M, Petzl DH, Schuster E, Woloszzuk W. Relationship between neopterin and granulo-cyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989; 17: 221–226.
  • Prates' C, Russo D, Dorigo W, Chiti E. Antibiotic pro-phylaxis in clean surgery: Vascular surgery. J Chemother 1999; 13 (spec issue 1): 123-128.
  • Foulds S, Cheshire NJ, Schachter M, Wolfe JH, Mansfield AO. Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair. Br J Surg 1997; 84: 172–177.
  • Holzheimer RG, Capel P, Cavaillon JM, et al. Immunological surrogate parameters in a prognostic model for multi-organ failure and death. Eur J Med Res 2000; 5 (7): 283–294.
  • Holzheimer RG, Schein M, Wittmann DH: Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe sec-ondary peritonitis. Arch Surg 1995, 130: 1314–1320.
  • Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anaesthesiology 1998; 89: 93–104.
  • MiMOZ O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early postraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185–188.
  • Strohmaier W, Redl H, Schlag G, Inthom D. D-erythro-neopterin plasma levels in intensive care patients with and with-out septic complications. Crit Care Med 1987; 15: 757–760.
  • Pacher R, Redl H, Frass M, Petzl DH, Schuster E, Woluszczuk W. Relationship between neopterin and granulo-cyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989; 17: 221–226.
  • Burleson DG, Johnson A, Salin M, Mason AD, Pruitt BA. Identification of neopterin as a potential indicator of infection in burned patients. Proc Soc Exp Biol Med 1992; 199: 305–310.
  • Delogu G, Casula MA, Mancini P, TelIan G, Signore L. Serum neopterin and soluble interleukin-2 receptor for predic-tion of a shock state in gram-negative sepsis. J Crit Care 1995; 10: 64–71.
  • Strohmaier W, Werner ER, Wachter H, Redl H, Schlag G. Pteridine and nitrite/nitrate formation in experimental sep-tic and traumatic shock. Shock 1996; 6: 254–258.
  • Yao YM, Yu K, Wang YP, Tian HM, Sheng ZY. Elevated serum neopterin level: its relation to endotoxemia and sepsis in patients with major burns. Eur J Clin Invest 1996; 26: 224–230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.